Cytel · 2 weeks ago
Clinical Executive Consultant – Vice President
Cytel is seeking a Vice President & Clinical Executive Consultant to join their Strategic Consulting Team, which focuses on delivering quantitative thought leadership in therapeutic product development. The role involves guiding strategic engagements for clients in the pharmaceutical, biotech, and medical device sectors, while enhancing Cytel's reputation for innovation and maintaining strong client relationships.
Responsibilities
Serve as an externally recognized thought leader in clinical development, regulatory strategy, market access strategy, and quantitative clinical methods
Provide strategic guidance to clients on optimizing clinical development plans, trial design, decision-making frameworks, and evidence generation
Develop new methodologies and thought leadership materials for dissemination through conferences, publications, and webinars
Lead business development, account management, and project execution across a broad and growing client portfolio
Identify emerging client needs and shape innovative solutions aligned with Cytel’s revenue, quality, and customer satisfaction objectives
Act as the primary point of contact for Strategic Design Consulting engagements, developing trusted, long-term partnerships with clients
Apply deep clinical development knowledge to design, initiate, and conduct effective clinical studies, integrating novel principles where appropriate
Serve as a subject matter expert for assigned accounts and therapeutic areas, collaborating with consultants and associates across Cytel
Maintain strong engagement with senior client leadership, regulatory agencies (FDA/EMA), and key opinion leaders to support and refine development strategies
Mentor and motivate a high-performing team of consultants and analysts; model excellence in strategic thinking and scientific rigor
Represent Cytel across the industry, demonstrating strong interpersonal leadership and the ability to influence stakeholders at all levels
Participate in cross-functional collaboration within Cytel’s Strategic Consulting and other business units
Qualification
Required
MD, MD/PhD; subspecialty training and/or clinical practice experience desirable
10+ years of experience in consulting, clinical trials, or health research environments
Demonstrated ability to understand and influence customer decision-making processes, with a track record of identifying and capturing transformational opportunities
Deep understanding of the biopharmaceutical R&D process, complemented by strong business acumen and appreciation of broader organizational and industry dynamics
Proven strategic thinker with global orientation, strong analytical skills, and the ability to execute tactically in complex environments
Demonstrated success in leading teams, mentoring junior colleagues, and driving high-impact consulting engagements
Experience interacting with regulatory agencies (FDA/EMA) and key opinion leaders to shape and enhance development plans
Ability to design and execute modern clinical studies and integrate them into cohesive clinical development strategies
Strong knowledge of disease areas or technical domains relevant to product development
Thorough understanding of clinical regulatory requirements, ICH/GCP guidelines, and ethical standards
Collaborative, entrepreneurial, self-motivated, and comfortable working in fast-paced, high-growth environments
Preferred
Expertise in related quantitative domains—such as adaptive designs, clinical pharmacology, data science, or model-informed drug development—is highly advantageous
Company
Cytel
Our mission is to improve success rates in this endeavor via the optimal design, effective implementation
H1B Sponsorship
Cytel has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (54)
2023 (37)
2022 (46)
2021 (43)
2020 (33)
Funding
Current Stage
Late StageTotal Funding
$2MKey Investors
New Mountain CapitalMerck Capital Ventures
2021-01-01Series Unknown
2020-12-21Acquired
2017-11-01Private Equity
Recent News
Adial Pharmaceuticals, Inc
2025-08-14
2025-06-11
Company data provided by crunchbase